Skip to content
Live newsroom 56 readers online
Friday, September 4, 2026 Live Sync: Just now
BreakingFor Gloria Steinem, fashion was about much more than aesthetics
Important AVOID INFY Stage 4 (Conv: 3/5 | Size: 10%)

Gland Pharma shares: Promoter Fosun Pharma likely to divest 5% equity worth Rs 2,279 crore via block deal

Fosun Pharma initiates stake sale in Gland Pharma amid robust quarterly growth and global market presence. Top Trending Stocks: SBI Share Price, Axis Bank Share Price, HDFC Bank Share Price, Infosys Share Price, Wipro Share Price, NTPC Share Price Top Trending Stocks: SBI Share Price, Axis Bank Share Price, HDFC Bank Share Price, Infosys Share […]

By deepak · September 3, 2026 · 1 min read

Fosun Pharma initiates stake sale in Gland Pharma amid robust quarterly growth and global market presence.

Top Trending Stocks: SBI Share Price, Axis Bank Share Price, HDFC Bank Share Price, Infosys Share Price, Wipro Share Price, NTPC Share Price

Top Trending Stocks: SBI Share Price, Axis Bank Share Price, HDFC Bank Share Price, Infosys Share Price, Wipro Share Price, NTPC Share Price

Is crude oil becoming a financial problem?

Q1 investment numbers look stellar, but are we celebrating too early?

Patent Cliff approaching: Can Indian pharma companies repeat past success?

ET Prime special: Bigger, Better or Both? Understanding business to figure out the mystery: Power Grid Corp – Part 1

ET Prime special series: 2013 to 2026. Not years, but evidence: Power Grid, Part 2

When a CFO resigns, is ‘personal reasons’ explanation enough?

Source: Read the original article on economictimes.indiatimes.com

Important Legal & Financial Disclaimer

FutureKnowledge is an automated financial intelligence aggregator. The information provided on this website does not constitute investment advice, financial advice, trading advice, or any other sort of advice and you should not treat any of the website's content as such. We are not registered with the SEC, SEBI, or any regulatory agency. Automated AI-generated content may contain errors. Always conduct your own due diligence and consult your financial advisor before making any investment decisions.

© 2026 FutureKnowledge Intelligence. All rights reserved.